Loading…

Labeling of human C-peptide by conjugation with N-succinimidyl-4-[18F]fluorobenzoate

We have labeled proinsulin connecting peptide (C‐peptide) with fluorine‐18 (t½=109.7 min) in order to perform in vivo biodistribution and pharmacokinetic studies with position emission tomography (PET). This study reports the optimization of the conjugation labeling in the N‐terminal with N‐succinim...

Full description

Saved in:
Bibliographic Details
Published in:Journal of labelled compounds & radiopharmaceuticals 2001-06, Vol.44 (7), p.509-519
Main Authors: Fredriksson, Anna, Johnström, Peter, Stone-Elander, Sharon, Jonasson, Per, Nygren, Per-Åke, Ekberg, Karin, Johansson, Bo-Lennart, Wahren, John
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have labeled proinsulin connecting peptide (C‐peptide) with fluorine‐18 (t½=109.7 min) in order to perform in vivo biodistribution and pharmacokinetic studies with position emission tomography (PET). This study reports the optimization of the conjugation labeling in the N‐terminal with N‐succinimidyl‐4‐[18F]fluorobenzoate ([18F]SFB). In preparative runs N‐4‐[18F]fluorobenzoyl‐C‐peptide ([18F]FB‐C‐peptide) was produced in 8–12% decay‐corrected yields, counted from resolubilized [18F]F−, in less than 5 h. The specific radioactivity of [18F]FB‐C‐peptide, determined using ELISA for one of the preparations, was around 70 GBq/μmol at end of synthesis. Copyright © 2001 John Wiley & Sons, Ltd.
ISSN:0362-4803
1099-1344
DOI:10.1002/jlcr.479